This creepy page turner has just been crowned best business book of the year

Maybe this holiday season, a part of you is looking to unwind with a jaw-dropping thriller full of jaw-dropping intrigue, outrageous villains, and determined heroes triumphing over terrifying obstacles. Maybe another part of you is saying, no, be wise and read a thought-provoking business book instead that will make you smarter.

Well I have some good news for you. You can do both at the same time.

The Financial Time and McKinsey just crowned their best annual business book of the year, and according to a host of jaw-dropping reviews, the winner will keep you awake all night reading and get you to think deeply about the culture and the flaws. of Silicon Valley.

the Wall Street newspaper journalist John Carreyrou won the award for Bad blood, her high-profile book detailing the meteoric rise and equally dramatic fall of blood testing startup Theranos and its once-celebrated, now vilified founder, Elizabeth Holmes.

Thriller-level suspense meets exhilarating insight

A quick glance at the book’s Amazon page will show you that the critics are united in their opinion of Carreyrou’s book – it’s a business book that reads like a thriller.

“You won’t want to let go of this fascinating and masterfully reported book,” enthused best-selling author Bethany McLean. “The authors of thrillers have nothing on [Carreyrou], agrees List of books, who calls the book a “captivating tour de force to read in one sitting”. The New York Times describes the book as “scary”.

But while almost everyone seems to agree Bad blood is a great choice if you want to spend a cool evening or a long plane trip with a propellant page turner, the book offers so much more than entertainment. The story’s incredible twists and turns and its deep dive into the character of Holmes also make readers think about what is wrong with the culture of startups to make fraud on such a scale possible.

This year’s award judges noted that the book “raised questions not only about the culture of a startup – at its peak valued at over $ 9 billion – but across Silicon Valley. The book offers an overview of the founding-leader cult and regulatory and corporate governance weaknesses, ”notes the FT article announcing the victory of Carreyrou.

Commenting on his victory, Carreyrou was even more candid in his assessment of the lessons to be learned from the book. Mr. Carreyrou said readers should learn from the Theranos scandal that the ‘go fast and break things’ approach’ doesn’t work very well ‘when lives are on the line,’ reports the FT.

So grab a copy, relax, and sit back for a long read. This book promises readers both a wild ride and plenty to think about.

The opinions expressed here by the columnists of are theirs and not those of